Delivery Order SPE2DB20D3101-SPE2DB24FRCJ5

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of NEXLIZET 180-10 MG TABLET pharmaceutical products, with a potential value of $1,021.33 and a completion date of January 19, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a prime contractor that provides...
This federal contract award is for the delivery of pharmaceutical products, specifically NEXLIZET 180-10 MG TABLET, to the Medical Supply Chain component of the Defense Logistics Agency (DLA). The fixed-price contract, valued at $1,861.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award with a ceiling value of $7,482.35 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside...
This federal contract award is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The firm-fixed-price contract has a ceiling value of $1,044.33 and runs through June 20, 2024. The contract was awarded without a set-aside designation. Amerisourcebergen holds a larger Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NEXLIZET 180-10 MG TABLET. The delivery order has a potential value of $1,847.14 and a completion date of January 9, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of supplying pharmaceuticals, medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,953.30 firm-fixed-price delivery order is for the supply of the medication NEXLIZET 180-10 MG TABLET UU 30S. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,218.27 by the Defense Logistics Agency (DLA) Troop Support Medical to provide NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. This delivery order contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,135.03, is for the delivery of NEXLIZET 180-10 MG TABLET medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,920.89, is for the supply of NEXLETOL 180 MG TABLET UU 30S, a prescription medication. The contract has a period of performance through February 24, 2025 and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRCJ5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NEXLIZET 180-10 MG TABLET UU 30S, with a total ceiling value of $2,796.76 and a period of performance through February 28, 2024. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 1:21 PM